ATE161967T1 - Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren - Google Patents

Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren

Info

Publication number
ATE161967T1
ATE161967T1 AT92912244T AT92912244T ATE161967T1 AT E161967 T1 ATE161967 T1 AT E161967T1 AT 92912244 T AT92912244 T AT 92912244T AT 92912244 T AT92912244 T AT 92912244T AT E161967 T1 ATE161967 T1 AT E161967T1
Authority
AT
Austria
Prior art keywords
virus
plasma
plasma samples
cells
respiratory virus
Prior art date
Application number
AT92912244T
Other languages
English (en)
Inventor
George R Siber
Jeanne Leszczynski
Original Assignee
Massachusetts Health Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Health Res filed Critical Massachusetts Health Res
Application granted granted Critical
Publication of ATE161967T1 publication Critical patent/ATE161967T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92912244T 1991-04-22 1992-04-10 Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren ATE161967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68843591A 1991-04-22 1991-04-22

Publications (1)

Publication Number Publication Date
ATE161967T1 true ATE161967T1 (de) 1998-01-15

Family

ID=24764406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912244T ATE161967T1 (de) 1991-04-22 1992-04-10 Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren

Country Status (13)

Country Link
US (2) US5412077A (de)
EP (1) EP0581882B1 (de)
JP (1) JPH06509866A (de)
AT (1) ATE161967T1 (de)
AU (2) AU668092B2 (de)
CA (1) CA2108259C (de)
DE (1) DE69223955T2 (de)
DK (1) DK0581882T3 (de)
ES (1) ES2113428T3 (de)
FI (1) FI110723B (de)
GR (1) GR3026393T3 (de)
NO (1) NO933697D0 (de)
WO (1) WO1992018652A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161967T1 (de) * 1991-04-22 1998-01-15 Massachusetts Health Res Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
DE69829400T2 (de) 1997-10-20 2006-04-13 Acambis, Inc., Cambridge Passive immunisierung gegen durch clostridium difficile verursachte krankheit
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
ES2349348T3 (es) * 2000-01-27 2010-12-30 Medimmune, Llc Anticuerpos neutralizantes de rsv de ultra alta afinidad.
CA2401652A1 (en) * 2000-03-01 2001-09-07 Medimmune, Inc. High potency recombinant antibodies and method for producing them
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US20050153382A1 (en) * 2002-06-06 2005-07-14 Chengdu Kuachang Science And Technology Co., Ltd. Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
CA2585891A1 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
SG10201602668VA (en) 2011-04-22 2016-05-30 Wyeth Llc Compositions relating to a mutant clostridium difficile toxin and methods thereof
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315073A (en) * 1979-10-26 1982-02-09 Cutter Laboratories, Inc. Titration of serum influenza antibody using plaque reduction neutralization test
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
US4665379A (en) * 1984-05-10 1987-05-12 Anes Electronics, Inc. Vehicle security system
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
ATE161967T1 (de) * 1991-04-22 1998-01-15 Massachusetts Health Res Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren

Also Published As

Publication number Publication date
DE69223955T2 (de) 1998-08-13
GR3026393T3 (en) 1998-06-30
ES2113428T3 (es) 1998-05-01
FI934657A0 (fi) 1993-10-21
AU680170B2 (en) 1997-07-17
EP0581882A1 (de) 1994-02-09
NO933697L (no) 1993-10-14
EP0581882A4 (en) 1994-06-08
FI110723B (fi) 2003-03-14
CA2108259C (en) 2003-12-09
DE69223955D1 (de) 1998-02-12
CA2108259A1 (en) 1992-10-23
US5412077A (en) 1995-05-02
AU1988592A (en) 1992-11-17
JPH06509866A (ja) 1994-11-02
EP0581882B1 (de) 1998-01-07
US5582827A (en) 1996-12-10
FI934657A (fi) 1993-10-21
DK0581882T3 (da) 1998-09-07
AU6067896A (en) 1996-10-17
WO1992018652A1 (en) 1992-10-29
AU668092B2 (en) 1996-04-26
NO933697D0 (no) 1993-10-14

Similar Documents

Publication Publication Date Title
ATE161967T1 (de) Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
Mann et al. The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
DANIELS Mechanisms of viral neutralization
Dietrich et al. Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates 1
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
DE69432043T2 (de) Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
ES8405952A1 (es) Un metodo de detectar un anticuerpo antivirus
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
WO1993025662A3 (en) Replication of hepatitis c virus genome and identification of virus having high infectivity
Monath et al. Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination
Leslie et al. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria: relationship with other blood borne viruses and liver disease
JPH05184361A (ja) 生物学的に活性なタンパク質の溶液中における低ｐＨでのリン酸トリ−（ｎ−ブチル）の殺ウイルス活性を増強するための使用
DE69128238T2 (de) Nachweis von thrombopenies
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
FI873233A0 (fi) Modifierade virala glykoproteiner.
DK162726C (da) Fremgangsmaade til eliminering af falsk positive resultater ved bestemmelse af atl virus-antistof og reagens dertil
Lafferty The relationship between molecular charge and the biological activity of antibody directed against rabbitpox virus
Hoekstra et al. Counter-Immunoelectrophoresis: Rapid Method for Detecting Group-Specific Antigen and Antibodies Associated with Oncogenic Ribonucleic Acid Viruses
SU1467513A1 (ru) Способ определени антигенов вирусов
Rheins et al. Reactivity of Globulins from Rheumatoid Sera in the Latex-Fixation Test.
Cox et al. Hemolysis of PR8-virus sensitized erythrocytes.
BE890338A (fr) Procede de preparation de solutions de lipoproteines a partir de residus de delipidation des plasmas et serums et utilisations de celles-ci
DK481484D0 (da) Fremgangsmaade til paavisning af virus
SHARP The sensitized sheep cell agglutination reaction in rheumatoid arthritis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee